← Back to Search

Behavioral Intervention

Integrated Dementia Care Interventions for Alzheimer's and Dementia

N/A
Waitlist Available
Led By Joshua Chodosh, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have two or more ICD-10 visit diagnoses (one of which must be ambulatory) for Alzheimer's Disease or Alzheimer's Disease Related Dementias (AD/ADRD)
Patients age 66 and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to help people living with dementia and their care partners access community support and services to improve care, satisfaction and reduce hospital visits.

Who is the study for?
This trial is for people aged 66 and older diagnosed with Alzheimer's or related dementias, who have had multiple health visits for these conditions. Their care partners must be adults over 18. It's not open to patients under the age of 66.
What is being tested?
The study tests three interventions: Nurse-led Telephonic Care (NLTC), Emergency Care Redesign (ECR), and Community Paramedic-led Transitions Intervention (CPTI) to improve post-emergency care for dementia patients.
What are the potential side effects?
Since this trial involves non-medical interventions like coaching and community support, traditional side effects are not expected; however, participants may experience changes in their usual care routines.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Alzheimer's or related dementia at least twice, once in an outpatient setting.
Select...
I am 66 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

8Treatment groups
Experimental Treatment
Active Control
Group I: Two interventions: NLTC and CPTIExperimental Treatment2 Interventions
Group II: Two interventions: ECR and CPTIExperimental Treatment2 Interventions
Group III: Two intervention: ECR and NLTCExperimental Treatment2 Interventions
Group IV: Single intervention: Nurse-led Telephonic Care (NLTC)Experimental Treatment1 Intervention
Group V: Single intervention: Emergency Care Redesign (ECR)Experimental Treatment1 Intervention
Group VI: Single intervention: Community Paramedic-led Transitions Intervention (CPTI)Experimental Treatment1 Intervention
Group VII: All interventions: ECR, NLTC, and CPTIExperimental Treatment3 Interventions
Group VIII: No interventionActive Control1 Intervention
No intervention, serving as a usual care control group

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,783 Previous Clinical Trials
28,165,023 Total Patients Enrolled
NYU Langone HealthLead Sponsor
1,408 Previous Clinical Trials
836,585 Total Patients Enrolled
Joshua Chodosh, MDPrincipal InvestigatorNYU Langone Health
5 Previous Clinical Trials
1,186 Total Patients Enrolled
~12800 spots leftby Aug 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top